AQR Arbitrage’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

AQR Arbitrage’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,500	Closed	-$668	–	1216
2022 Q4	$668	Hold	37,500	–	–	﹤0.01%	1187
2022 Q3	$3K	Hold	37,500	–	–	﹤0.01%	1326
2022 Q2	$3K	Hold	37,500	–	–	﹤0.01%	1437
2022 Q1	$8K	Hold	37,500	–	–	﹤0.01%	1292
2021 Q4	$365K	Hold	37,500	–	–	0.01%	997
2021 Q3	$22K	Hold	37,500	–	–	﹤0.01%	1072
2021 Q2	$29K	Buy	+37,500	New	+$22.8K	﹤0.01%	1039

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

AQR Arbitrage's IBER.WS Position: Q1 2023 in Review

AQR Arbitrage sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 37,500 shares — an estimated $668 sold.

AQR Arbitrage first reported a position in IBER.WS in Q2 2021 and held it in 7 quarters. The position peaked at $365K in Q4 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

AQR Arbitrage reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
AQR Arbitrage sold 37,500 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $668.
AQR Arbitrage first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2021 and held it in 7 quarters.
AQR Arbitrage's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $365K in Q4 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.